Summary

According to our latest study on " Continuous Renal Replacement Therapy Market Forecast to 2030 – Global Analysis –Product, Modality, End User, and Geography," the market was valued at US$ 1.42 billion in 2022 and is expected to reach US$ 2.75 billion by 2030; it is estimated to register a CAGR of 8.7% from 2022 to 2030.

Continuous renal replacement therapy (CRRT) has become the recommended dialysis option for children admitted to ICUs for AKI treatments. The indications for renal replacement in the pediatric population have changed due to a wide range of pediatric diseases. The range of CRRT applications has expanded with its proven effectiveness in treating nonrenal indications, primarily, in critically ill newborns. For instance, the Carpediem system by Medtronic offers a dedicated extracorporeal CRRT for low-weight patients; as per the company’s claims, the device responds effectively to the needs of the most fragile patients. Moreover, PRISMASOL and PHOXILLUM solutions by Baxter are indicated as a replacement solution in CRRT to replace plasma volume removed by ultrafiltration as well as to correct electrolyte and acid-base imbalances in pediatric and adult patients. Thus, the increased demand for pediatric CRRT devices benefits the continuous renal replacement therapy market growth.

By Product, Continuous Renal Replacement Therapy Market-Based Insights

Based on product, the continuous renal replacement therapy market is segmented into dialysates and replacement fluids, disposables, bloodline sets and tubes, CRRT systems, and hemofilters. The CRRT systems segment held the largest share of the market in 2022. The hemofilters segment is likely to register the highest CAGR in the market during 2022–2030. The hemofilters are composed of a hollow-fiber membrane that controls the volume of fluids and solutes evacuated. By eliminating solutes (waste products, electrolytes, and other molecules), CRRT hemofilter membranes imitate some of the activities of the kidney. Moreover, they may help restore fluid status and acid-base balance through their function.

By End User, Continuous Renal Replacement Therapy Market-Based Insights

The continuous renal replacement therapy market, by end-user, is segmented into hospitals, ambulatory care centers, home care, and others. In 2022, the hospital segment dominated the continuous renal replacement therapy market share. The home monitoring segment is expected to register the highest CAGR during 2022–2030. In 2023, the US had 5,157 community hospitals, 206 federal government hospitals, and 107 other hospitals, according to the American Hospital Association. Further, the growing elderly population and the notable rise in hospital admissions for AKI are the key factors that propel the demand for CRRT systems in hospitals.

National Institutes of Health, company’s investor reports, and the World Health Organization, are a few of the major secondary sources referred to while preparing the report on the continuous renal replacement therapy market.

ページTOPに戻る

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. Research Methodology
4. Continuous Renal Replacement Therapy Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. Continuous Renal Replacement Therapy Market - Key Market Dynamics
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. Continuous Renal Replacement Therapy Market - Global Market Analysis
6.1 Continuous Renal Replacement Therapy - Global Market Overview
6.2 Continuous Renal Replacement Therapy - Global Market and Forecast to 2030
7. Continuous Renal Replacement Therapy Market – Revenue Analysis (USD Million) – By Product, 2020-2030
7.1 Overview
7.2 Dialysates and Replacement Fluids
7.3 Disposables
7.4 Bloodline Sets and Tubes
7.5 Hemofilters
7.6 CRRT Systems
8. Continuous Renal Replacement Therapy Market – Revenue Analysis (USD Million) – By Modality, 2020-2030
8.1 Overview
8.2 Continuous venovenous hemofiltration (CVVH)
8.3 Continuous venovenous hemodiafiltration (CVVHDF)
8.4 Continuous venovenous hemodialysis (CVVHD)
8.5 Slow continuous ultrafiltration (SCUF)
9. Continuous Renal Replacement Therapy Market – Revenue Analysis (USD Million) – By End User, 2020-2030
9.1 Overview
9.2 Hospital
9.3 Ambulatory care
9.4 Homecare
9.5 Others
10. Continuous Renal Replacement Therapy Market - Revenue Analysis (USD Million), 2020-2030 – Geographical Analysis
10.1 North America
10.1.1 North America Continuous Renal Replacement Therapy Market Overview
10.1.2 North America Continuous Renal Replacement Therapy Market Revenue and Forecasts to 2030
10.1.3 North America Continuous Renal Replacement Therapy Market Revenue and Forecasts and Analysis - By Product
10.1.4 North America Continuous Renal Replacement Therapy Market Revenue and Forecasts and Analysis - By Modality
10.1.5 North America Continuous Renal Replacement Therapy Market Revenue and Forecasts and Analysis - By End User
10.1.6 North America Continuous Renal Replacement Therapy Market Revenue and Forecasts and Analysis - By Countries
10.1.6.1 United States Continuous Renal Replacement Therapy Market
10.1.6.1.1 United States Continuous Renal Replacement Therapy Market, by Product
10.1.6.1.2 United States Continuous Renal Replacement Therapy Market, by Modality
10.1.6.1.3 United States Continuous Renal Replacement Therapy Market, by End User
10.1.6.2 Canada Continuous Renal Replacement Therapy Market
10.1.6.2.1 Canada Continuous Renal Replacement Therapy Market, by Product
10.1.6.2.2 Canada Continuous Renal Replacement Therapy Market, by Modality
10.1.6.2.3 Canada Continuous Renal Replacement Therapy Market, by End User
10.1.6.3 Mexico Continuous Renal Replacement Therapy Market
10.1.6.3.1 Mexico Continuous Renal Replacement Therapy Market, by Product
10.1.6.3.2 Mexico Continuous Renal Replacement Therapy Market, by Modality
10.1.6.3.3 Mexico Continuous Renal Replacement Therapy Market, by End User
Note - Similar analysis would be provided for below mentioned regions/countries

10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Rest of Europe
10.3 Asia-Pacific
10.3.1 Australia
10.3.2 China
10.3.3 India
10.3.4 Japan
10.3.5 South Korea
10.3.6 Rest of SouthEast Asia
10.4 Middle East and Africa
10.4.1 South Africa
10.4.2 U.A.E
10.4.3 Rest of Middle East and Africa
10.5 South and Central America
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Rest of South and Central America
11. Industry Landscape
11.1 Mergers and Acquisitions
11.2 Agreements, Collaborations, Joint Ventures
11.3 New Product Launches
11.4 Expansions and Other Strategic Developments
12. Competitive Landscape
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning and Concentration
13. Continuous Renal Replacement Therapy Market - Key Company Profiles
13.1 Baxter International Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
Note - Similar information would be provided for below list of companies

13.2 Asahi Kasei
13.3 Fresenius Medical Care
13.4 Medica S.p.A.
13.5 Medtronic Plc
13.6 B. Braun
13.7 Nikkiso Co Ltd
13.8 Toray Medical Co Ltd
13.9 Infomed SA
13.10 Quanta Dialysis Technologies Inc
14. Appendix
14.1 Glossary
14.2 About The Insight Partners
14.3 Market Intelligence Cloud